Healthy Skepticism Library item: 6894

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: report

Therapeutic Products Programme
Discussion document: direct-to-consumer advertising of prescription drugs
1999 Apr 6
www.hc-sc.gc.ca/hpb-dgps/therapeut/htmleng/consult_dtca.html

Abstract:

This is a background document that discusses: the current advertising regulatory framework and environment in Canada; the situation with respect to direct-to-consumer advertising in the United States, the European Union and New Zealand; the Canadian consultations to date on DTCA; and what current considerations are. Appendices to the document deal with: the role of Advertising Standards Canada in regulating promotion of over-the-counter medications and the Pharmaceutical Advertising Advisory Board in controlling advertising directed at health professionals; an outline of planned research on DTCA in the United States and Canada; and a brief literature review of the issue.

Keywords:
*nonsystematic review/*analysis/Canada/United States/European Union/New Zealand/DTCA/direct-to-consumer advertising/regulation of promotion/Pharmaceutical Advertising Advisory Board (Can)/Advertising Standards Canada/attitude toward promotion/safety & risk information/doctors/pharmacies and pharmacists/general public and consumers/patients/ATTITUDES REGARDING PROMOTION: CONSUMERS/PATIENTS/ATTITUDES REGARDING PROMOTION: HEALTH PROFESSIONALS/EVALUATION OF PROMOTION: DIRECT-TO-CONSUMER ADVERTISING/INFLUENCE OF PROMOTION: HEALTH AND HEALTH CARE/REGULATION, CODES, GUIDELINES: AUTONOMOUS BODIES/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION